Economic methods in the century trial--a comprehensive lifestyle modification study for managing coronary artery

James R Langabeer1, Rigoberto Delgado, David Lairson

  • 1Center for Emergency Research, University of Texas School of Public Health, 1200 Herman Pressler Street, RAS-W310, Houston, TX 77030, USA. James.R.Langabeer@uth.tmc.edu

Insights

The Century Trial investigates the cost-effectiveness of lifestyle changes for coronary artery disease (CAD). This study combines imaging and education to improve patient health and behavior, offering valuable economic insights.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Preventive Cardiology

Background:

  • Most studies focus on acute coronary conditions, but the Century Trial addresses coronary artery disease (CAD) through lifestyle modification.
  • The Century Trial is a phase III randomized study with 1,300 patients, focusing on preclinical or established CAD.
  • It uniquely combines positron emission tomography imaging with educational and motivational therapy.

Purpose of the Study:

  • To present the economic study design of the Century Trial for reference by other researchers.
  • To detail cost and effect estimation methods, analysis, and uncertainty modeling.
  • To provide evidence on the cost-effectiveness of comprehensive lifestyle modification programs in regressing CAD.

Main Methods:

  • Utilizes positron emission tomography for risk stratification in 1,300 patients.
  • Employs comprehensive educational and motivational therapy for CAD patients.
  • Incorporates quality-adjusted life years and a societal perspective for cost measurement.

Main Results:

  • The study is in its second year of a five-year follow-up.
  • It aims to measure in-trial and lifetime costs using incremental cost-effectiveness ratios.
  • The economic evaluation will assess the value of lifestyle interventions in CAD management.

Conclusions:

  • The Century Trial offers methodological detail for economic evaluations of lifestyle modification programs.
  • It is expected to yield significant evidence on the cost-effectiveness of comprehensive CAD regression strategies.
  • The findings will contribute to understanding the economic benefits of integrating advanced imaging with behavioral interventions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...